BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martín Giménez VM, Noriega SE, Kassuha DE, Fuentes LB, Manucha W. Anandamide and endocannabinoid system: an attractive therapeutic approach for cardiovascular disease. Ther Adv Cardiovasc Dis 2018;12:177-90. [PMID: 29764302 DOI: 10.1177/1753944718773690] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Martín Giménez VM, Díaz-rodríguez P, Sanz RL, Vivero-lopez M, Concheiro A, Diez E, Prado N, Enrique Kassuha D, Alvarez-lorenzo C, Manucha W. Anandamide-nanoformulation obtained by electrospraying for cardiovascular therapy. International Journal of Pharmaceutics 2019;566:1-10. [DOI: 10.1016/j.ijpharm.2019.05.047] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
2 Hahnefeld L, Gurke R, Thomas D, Schreiber Y, Schäfer SM, Trautmann S, Snodgrass IF, Kratz D, Geisslinger G, Ferreirós N. Implementation of lipidomics in clinical routine: Can fluoride/citrate blood sampling tubes improve preanalytical stability? Talanta 2020;209:120593. [DOI: 10.1016/j.talanta.2019.120593] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
3 Navarrete C, Garcia-Martin A, DeMesa J, Muñoz E. Cannabinoids in Metabolic Syndrome and Cardiac Fibrosis. Curr Hypertens Rep 2020;22:98. [PMID: 33089434 DOI: 10.1007/s11906-020-01112-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Bondarenko AI. Cannabinoids and Cardiovascular System. Adv Exp Med Biol 2019;1162:63-87. [PMID: 31332735 DOI: 10.1007/978-3-030-21737-2_5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
5 Martín Giménez VM, Chuffa LGA, Simão VA, Reiter RJ, Manucha W. Protective actions of vitamin D, anandamide and melatonin during vascular inflammation: Epigenetic mechanisms involved. Life Sci 2022;288:120191. [PMID: 34856208 DOI: 10.1016/j.lfs.2021.120191] [Reference Citation Analysis]
6 Liu X, Wu Y, Zhou D, Xie Y, Zhou Y, Lu Y, Yang R, Liu S. N‑linoleyltyrosine protects PC12 cells against oxidative damage via autophagy: Possible involvement of CB1 receptor regulation. Int J Mol Med 2020;46:1827-37. [PMID: 33000188 DOI: 10.3892/ijmm.2020.4706] [Reference Citation Analysis]
7 Gurke R, Thomas D, Schreiber Y, Schäfer SMG, Fleck SC, Geisslinger G, Ferreirós N. Determination of endocannabinoids and endocannabinoid-like substances in human K3EDTA plasma - LC-MS/MS method validation and pre-analytical characteristics. Talanta 2019;204:386-94. [PMID: 31357310 DOI: 10.1016/j.talanta.2019.06.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
8 Martín Giménez VM, Mocayar Marón FJ, García S, Mazzei L, Guevara M, Yunes R, Manucha W. Central nervous system, peripheral and hemodynamic effects of nanoformulated anandamide in hypertension. Adv Med Sci 2021;66:72-80. [PMID: 33388673 DOI: 10.1016/j.advms.2020.12.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Baranowska-Kuczko M, Kozłowska H, Kloza M, Kusaczuk M, Harasim-Symbor E, Biernacki M, Kasacka I, Malinowska B. Vasoprotective Endothelial Effects of Chronic Cannabidiol Treatment and Its Influence on the Endocannabinoid System in Rats with Primary and Secondary Hypertension. Pharmaceuticals (Basel) 2021;14:1120. [PMID: 34832902 DOI: 10.3390/ph14111120] [Reference Citation Analysis]
10 Karimian Azari E, Kerrigan A, O’connor A. Naturally Occurring Cannabinoids and their Role in Modulation of Cardiovascular Health. Journal of Dietary Supplements 2020;17:625-50. [DOI: 10.1080/19390211.2020.1790708] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Dimmito MP, Stefanucci A, Della Valle A, Scioli G, Cichelli A, Mollica A. An overview on plants cannabinoids endorsed with cardiovascular effects. Biomed Pharmacother 2021;142:111963. [PMID: 34332376 DOI: 10.1016/j.biopha.2021.111963] [Reference Citation Analysis]
12 Hernández-Díaz C, Juárez-Oropeza MA, Mascher D, Pavón N, Regla I, Paredes-Carbajal MC. Effects of Oleamide on the Vasomotor Responses in the Rat. Cannabis Cannabinoid Res 2020;5:42-50. [PMID: 32322675 DOI: 10.1089/can.2019.0014] [Reference Citation Analysis]
13 Dobrzyńska I, Szachowicz-petelska B, Pędzińska-betiuk A, Figaszewski ZA, Skrzydlewska E. Effects of hypertension and FAAH inhibitor treatment of rats with primary and secondary hypertension considering the physicochemical properties of erythrocytes. Toxicology Mechanisms and Methods 2020;30:297-305. [DOI: 10.1080/15376516.2020.1727595] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Li X, Peng Z, Zhou Y, Wang J, Lin X, Dong X, Liu X, Jiang J, Jiang Y, Li L. Quetiapine induces myocardial necroptotic cell death through bidirectional regulation of cannabinoid receptors. Toxicol Lett 2019;313:77-90. [PMID: 31220554 DOI: 10.1016/j.toxlet.2019.06.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
15 Biernacki M, Baranowska-Kuczko M, Niklińska GN, Skrzydlewska E. The FAAH Inhibitor URB597 Modulates Lipid Mediators in the Brain of Rats with Spontaneous Hypertension. Biomolecules 2020;10:E1022. [PMID: 32664225 DOI: 10.3390/biom10071022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Rabino M, Mallia S, Castiglioni E, Rovina D, Pompilio G, Gowran A. The Endocannabinoid System and Cannabidiol: Past, Present, and Prospective for Cardiovascular Diseases. Pharmaceuticals (Basel) 2021;14:936. [PMID: 34577636 DOI: 10.3390/ph14090936] [Reference Citation Analysis]